Red Cross & Pharmaceuticals Research Company Team Up to Fight Disease

GENEVA—Non-communicable diseases cause deaths all over the world, but three organizations in the EU have teamed up to fight non-communicable diseases in an unprecedented cross-sector partnership.

The International Federation of Red Cross and Red Crescent Societies (IFRC) has partnered with the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) to develop a toolkit that will help educate those at-risk of developing non-communicable diseases, and helping them to make the behavioral and social changes necessary to protect themselves.


image credit

The packet not only promotes making healthy individual lifestyle choices, but also healthy local community choices, and national choices. The relationship of the IFRC to the community will help them distribute the packet to more than 3 million people throughout the world, most in low- to middle-income countries, where more than 80 per cent of non-communicable disease-related deaths occur each year.

A recent report from the United Nations called for research and medical firms, and relief agencies to fight against non-communicable diseases. The report indicated that the four main types of non-communicable diseases—cancer, diabetes, chronic respiratory disease, and cardiovascular disease—cause more than 60 per cent of the roughly 35 million deaths that occur worldwide every year. According to recent reports, around 50 per cent of non-communicable disease-related deaths are avoidable, and the risk can be mitigated by simple changes in lifestyle and habits.

The partnership between IFRC and IFPMA will help both organizations to implement and strengthen community-based health interventions aimed at reducing the impact of non-communicable diseases on communities worldwide. The partnership makes sense. Both the IFRC and the IFPMA are uniquely situated to fight non-communicable diseases at the local level. The creative approaches brought into the partnership by both of the organizations provide the two-year partnership with a synergy that will make their combined efforts more impactful and successful.

In 2011, the IFPMA released a Framework for Action on Non-Communicable Diseases, and has also developed a wide variety of health education initiatives and research projects aimed at not only educating the public on healthy lifestyle choices that can help them to both avoid and combat non-communicable diseases, but also towards finding a cure for these deadly diseases.

Non-communicable diseases are a major target of the United Nations, the IFRC, and the IFPMA because they are preventable most of the time. Some of the most common factors that increase a person’s risk for developing a non-communicable disease include obesity, lack of exercise, overuse of alcohol products, and tobacco use. Non-communicable diseases are especially treacherous because they are likely to cause long-term detriment and death, can create a necessity for lifelong medical care which many people may not be able to afford, and are caused in most cases by a person’s own actions or lack of action and not by an infection or communicable illness.

In late 2012, the World Health Organization released its 25 indicators of progress, which the partnership between IFRC and IFPMA are working to address.

Claire Al-Aufi

Claire Al-Aufi is a contributing author for Hive Health Media who provides updates on health and fitness news.

One thought on “Red Cross & Pharmaceuticals Research Company Team Up to Fight Disease

  • May 2, 2013 at 4:43 pm

    “The partnership makes sense.” It sure does. None of them can be trusted, so it does make sense. I stopped trusting the Red Cross over 20 years ago, because of their shenanigans and trust Big Pharma; never have trusted them.


Leave a Reply

Your email address will not be published. Required fields are marked *